Division Chief, Clinical Cancer Genetics, Yale School of Medicine; Asst Director, Clinical Cancer Genetics, Yale Cancer Center; Opinions my own
YSM, YCC, Smilow Cancer Hosp
Joined March 2017
- Tweets150
- Following86
- Followers440
- Likes165
Important symposium on fertility preservation which impacts patients with early onset cancer and their families. Discussed state-of-the-art care and multi-D programs. @SmilowCancer @YaleCancer @YaleMed
Important education and conversation on #fertility care for patients with #cancer and hematological disorders at our “Preserving Hope” conference hosted by @DrEricWiner, Dr. Hugh Taylor, @vedangiri, and Dr. Nancy Borstelmann. @YaleCancer @YaleMed @YNHH
Honored to work with expert colleagues nationally and globally for this effort. We hope this will be a helpful model to reduce PCA disparities in genetic testing. @YaleCancer @YaleMed
A socioecological model proposed in this new study from @vedangiri et al implements equitable strategies dedicated to ⬆️engagement of Black males in #prostatecancer genetic testing which is critical to ⬇️ disparities in mortality.
bmcpublichealth.biomedcentra…
@SmilowCancer @YaleMed @YNHH @BMC_series
It was a terrific forum and honored to have been a part of it! @PCFnews #WomenInScience
The @PCFnews #WomenInScience Forum: Empowering female researchers through networking and mentorship. @vedangiri, @AyeshaShafi_PhD, & @Fletcher_C join @AndreaMiyahira in this discussion on UroToday > bit.ly/48oKt3l
Totally agree! What a fun and inspiring group! @ASCO
I’m so proud to be part of this brilliant and fun @ASCO #guidelines group! @EnriqueSoto8 @vedangiri @BryanRumble @BrittanyEHarvey and more!
Excited for the Early Onset Cancer Program to improve outcomes and quality of life for younger adults with cancer, their families, and their loved ones. @YaleCancer
Our Early Onset Cancer Program focuses on patients with #cancer btw ages 18-49 + will address psychosocial needs, novel clinical care models, enhance #clinicaltrials, expand research, and community awareness. bit.ly/47irRCh @SmilowCancer @YaleMed @YNHH @vedangiri
Thank you @urotoday and @CaPsurvivorship for opportunity to highlight TARGET study results at ASCO 2023! Excited to have worked with terrific collaborators @LoebStacy @heatherhcheng
Patient-driven webtool challenges traditional counseling in #ProstateCancer germline testing. @vedangiri @YaleCancer joins @CaPsurvivorship @DanaFarber to discuss the promising results of the #TARGET study on UroToday > bit.ly/44RuE3s
What a wonderful conference- surrounded by brilliant minds coming together to address big questions to reduce PCA mortality #PCFAcademy @PCF_Science
Wonderful start to session II on implementation of genetic testing by Dr. Veda Giri @vedangiri highlighting current PCa studies designed to evaluate different design/methods of implantations. #PCFAcademy @PCF_Science
It was my pleasure! Wonderful to build collaborations with Urology colleagues and reconnect with an esteemed Visiting Professor!
A special thanks to @vedangiri, MD, for our showcase talk today!
"Urology is a key gateway into identifying hereditary cancer..."
@YaleMed #VisitingProfessorDay #genetics
Such an honor to serve as Chair of ASCO Evidence Based Medicine Committee this year - what a terrific ASCO team! #ASCO2023 @BrittanyEHarvey @geisel_rachel @BryanRumble
Very excited to work with a stellar team of investigators @LoebStacy @heatherhcheng for the TARGET study. Grateful for PCF Challenge Award funding @PCFnews @PCF_Science #ASCO2023
.@vedangiri shares new research supporting a new standard of care for the use of patient-driven web tools for expanding access to decision making for genetic testing. @OncoAlert @SmilowCancer @YaleMed @YNHH
Grateful to work with an excellent team of investigators for PROGRESS Registry. Many thanks to @young_whang for presenting the abstract. Thank you @urotoday for article and enhancing impact!@YaleCancer @SmilowCancer @YNHH
Today at 2:30pm EST, Dr. Veda Giri @vedangiri presents "Factors related to men's experience with #prostatecancer germline testing" during Poster Session A at @ASCO GU Cancers Symposium #GU23.
@SmilowCancer @YaleMed @YNHH
We all can make a difference during #NationalCancerPreventionMonth and beyond by spreading the message of importance of cancer screening, healthy lifestyle, and knowing family history of cancer-one individual, family, and community at a time! @YaleCancer
February is #NationalCancerPreventionMonth. Learn more about #cancer risk and hereditary #cancergenetics at our webinar, "Smilow Shares: Understanding Your Cancer Risk and Prevention," on Feb. 23 at 7pm.
Register: bit.ly/3wHw3L1. @vedangiri
@SmilowCancer @YaleMed @YNHH
Veda Giri retweeted
New podcast series offering information on genetic testing for prostate cancer has featured medical oncologists, genetic counselors, and a patient. #urology #urologist #pcsm @vedangiri @LoebStacy @Yale_Urology
Watch now: urologytimes.com/view/prosta…
Veda Giri retweeted
On this week's Prostate Cancer Genetics Podcast, @vedangiri and I spoke to a patient with #prostatecancer about his experience with genetic testing and #BRCA2. Check out the full episode: bit.ly/3WAGR8j @ZEROCancer @PCFnews @AmerUrological @UrologyTimes
Veda Giri retweeted
New prospective data that PODCASTS are a useful way to share education about #prostatecancer genetics! Hot off the press in @pcan_journal w @vedangiri -free full-text access: rdcu.be/c3UEl You can also check out the initial podcast episodes here: open.spotify.com/show/4FYxW2…
Veda Giri retweeted
Hot off the press: Genetic Risk Prediction for #ProstateCancer: Implications for Early Detection and Prevention HT @TylerSbrt @a_plym @BrandonMahal @vedangiri @heatherhcheng @prost8helf @wandering_gu sciencedirect.com/science/ar…
Veda Giri retweeted
Experts study implications of genetic markers in prostate cancer urologytimes.com/view/expert… #urology #urologist #prostatecancer #pcsm @LoebStacy @vedangiri
Great working with ASCO team on this exciting new pathway for guidelines #ASCO
@ASCO's #livingguideline methodology represents the future of guideline development.
Great working w/ @BryanRumble, @vedangiri, #TomOliver and @JCO_ASCO editors Jonathan Friedberg & Kathy Miller on this editorial: ascopubs.org/doi/full/10.120…
Veda Giri retweeted
Involved with genomic testing in prostate cancer? Please take our survey precision-registry.com/decid… - it is for anyone in clinical, research, or industry domains. Thank you to everyone who has already helped in disseminating. Please spread far and wide! Supported by @PCF_Science
Thrilled to be joining the Yale Cancer Center and Yale School of Medicine to lead clinical cancer genetics and serve the needs of our patients and communities through cutting-edge clinical care, research, and advocacy!@YaleMed @SmilowCancer and Yale Cancer Center @YNHH
Veda Giri, MD @vedangiri, has been named Chief of the Division of Clinical Cancer Genetics for @SmilowCancer and Yale Cancer Center. Welcome Dr. Giri! @YaleMed @YNHH
